Clinical Trial Update: Study of Safety and Efficacy of HLX01+MTX in Patients With Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating HLX01 plus methotrexate in moderately to severely active rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• HLX01 (null)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Shanghai Henlius Biotech | Conditions: Moderately to Severely Active Rheumatoid Arthritis | Phase 3 | Status: COMPLETED